Showing results (531-540 of 831) with videos related to
Sort By:
Pageof 84
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 16, 2021
Vaccination History and Risk of Lymphoma and Its Major SubtypesGeffen Kleinstern, Melissa C Larson, Stephen M Ansell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2024
Risk of Incident Melanoma Among Individuals With Low-Count Monoclonal B-Cell LymphocytosisBryan A Vallejo, Ahmed Ansari, Sameer A Parikh, et al.British Journal of Haematology|October 3, 2002
Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukaemia and are associated with reduced survivalFrancis J Giles, Hagop M Kantarjian, B Nebiyou Bekele, et al.Blood|August 1, 2002
The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemiaAlessandra Ferrajoli, Michael J Keating, Taghi Manshouri, et al.Blood|August 9, 2011
Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemiaFarhad Ravandi, Susan O'Brien, Jeffrey Jorgensen, et al.Blood|June 17, 2004
Long-term survival benefit and improved complete cytogenetic and molecular response rates with imatinib mesylate in Philadelphia chromosome-positive chronic-phase chronic myeloid leukemia after failure of interferon-alphaHagop M Kantarjian, Jorge E Cortes, Susan O'Brien, et al.British Journal of Haematology|June 27, 2007
Biphenotypic acute leukaemia: a case seriesAhmed Aribi, Carlos Bueso-Ramos, Eli Estey, et al.Blood|December 26, 2008
Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome-negative acute lymphocytic leukemiaHui Yang, Tapan Kadia, Lianchun Xiao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2007
Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemiaSusan O'Brien, Joseph O Moore, Thomas E Boyd, et al.Blood|October 24, 2002
Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia: high incidence of early complete and major cytogenetic responsesHagop M Kantarjian, Jorge E Cortes, Susan O'Brien, et al.Pageof 84